616 Pharmacokinetics and Safety of a Subcutaneous Formulation of Nivolumab (NIVO SC) Monotherapy: Updated Results from the Phase 1/2 CheckMate 8KX Study
Journal for ImmunoTherapy of Cancer(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined